To further investigate the potential pathways linking CHEK2 and TP53-mutated HCC cells, we initially divided samples into three groups in TCGA, ICGC, and GAO et al. databases: high CHEK2/TP53 mutation, low CHEK2/TP53 wild, and mixed. Here, CHEK2 is linked to hepatocellular carcinoma.